Skip to main content Accessibility help
×
Home

Functional deficits and other psychiatric associations with abnormal scores on the Montreal Cognitive Assessment (MoCA) in older HIV-infected patients

  • James A. Bourgeois (a1), Malcolm John (a2), Roland Zepf (a2), Meredith Greene (a3), Steven Frankel (a4) and Nancy A. Hessol (a5)...

Abstract

Objective:

The authors assessed the association of physical function, social variables, functional status, and psychiatric co-morbidity with cognitive function among older HIV-infected adults.

Design:

From 2012–2014, a cross-sectional study was conducted among HIV-infected patients ages 50 or older who underwent comprehensive clinical geriatric assessment.

Setting:

Two San Francisco HIV clinics.

Participants:

359 HIV-infected patients age 50 years or older

Measurements

Unadjusted and adjusted Poisson regression measured prevalence ratios and 95% confidence intervals for demographic, functional and psychiatric variables and their association with cognitive impairment using a Montreal Cognitive Assessment (MoCA) score < 26 as reflective of cognitive impairment.

Results

Thirty-four percent of participants had a MoCA score of < 26. In unadjusted analyses, the following variables were significantly associated with an abnormal MoCA score: born female, not identifying as homosexual, non-white race, high school or less educational attainment, annual income < $10,000, tobacco use, slower gait speed, reported problems with balance, and poor social support. In subsequent adjusted analysis, the following variables were significantly associated with an abnormal MoCA score: not identifying as homosexual, non-white race, longer 4-meter walk time, and poor social support. Psychiatric symptoms of depressive, anxiety, and post-traumatic stress disorders did not correlate with abnormal MoCA scores.

Conclusions:

Cognitive impairment remains common in older HIV-infected patients. Counter to expectations, co-morbid psychiatric symptoms were not associated with cognitive impairment, suggesting that cognitive impairment in this sample may be due to neurocognitive disorders, not due to other psychiatric illness. The other conditions associated with cognitive impairment in this sample may warrant separate clinical and social interventions to optimize patient outcomes.

Copyright

Corresponding author

Correspondence should be addressed to: James A. Bourgeois, Chair, Department of Psychiatry, Baylor Scott & White Health, Central Texas Division, 2401 South 31st Street, Temple, TX 76508, USA. Phone: 254-724-5752; Fax: 254-724-1747. Email: James.Bourgeois@BSWHealth.org.

References

Hide All
Ammassari, A. et al. (2004). Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons. Psychosomatics, 45, 394402. doi: 10.1176/appi.psy.45.5.394.
Ances, B. M. and Ellis, R. J. (2007). Dementia and neurocognitive disorders due to HIV-1 infection. Seminars in Neurology, 27, 8692.
Anderson, A. M. et al. (2017). Prevalence and correlates of persistent HIV-1 RNA in cerebrospinal fluid during antiretroviral therapy. The Journal of Infectious Diseases, 215, 105113.
Applebaum, A. and Brennan, M. (2009). Mental health and depression. In Brennan, M., Karpiak, S. E., Cantor, M. H. and Shippy, R. A. (eds.) Research on Older Adults with HIV: An in-depth Examination of an Emerging Population (pp. 2734). New York, NY: Nova Science Publishers.
Atkinson, J. H. et al. (2009). Psychiatric context of acute/early HIV infection. The NIMH Multisite Acute HIV Infection Study: IV. AIDS and Behavior, 13, 10611067.
Becker, J. T. et al. (2011). Subcortical brain atrophy persists even in HAART-regulated HIV disease. Brain Imaging and Behavior; 5, 7785.
Bohnert, K. M. and Breslau, N. (2011). Assessing the performance of the short screening scale for post-traumatic stress disorder in a large nationally-representative survey. International Journal of Methods in Psychiatric Research, 20, e1e5.
Brito e Silva, E. T., Caixeta, L. F., Soares, V. L. and Sagawa, G. R. (2011). HIV-associated dementia in older adults: clinical and tomographic aspects. International Psychogeriatrics, 23, 10611069. doi: 10.1017/S1041610210002474.
Brown, R. L. and Rounds, L. A. (1995). Conjoint screening questionnaires for alcohol and other drug abuse: criterion validity in a primary care practice. Wisconsin Medical Journal, 94, 135140.
Centers for Disease Control and Prevention (2014). Diagnoses of HIV Infection in the United States and Dependent Areas, 2014. Retrieved from https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-report-us.pdf1.
Crane, H. M., Van Rompaey, S. E., Dillingham, P. W., Herman, E., Diehr, P. and Kitahata, M. M. (2006). A single-item measure of health-related quality-of-life for HIV-infected patients in routine clinical care. AIDS Patient Care and STDs, 20, 161174.
Cross, S., Onen, N., Gase, A., Overton, T. E. and Ances, B. M. (2013). Identifying risk factors for HIV-associated neurocognitive disorders using the International HIV Dementia Scale. Journal of Neuroimmune Pharmacology, 8, 11141122. doi: 10.1007/s11481-01309505-1.
Cutrona, C., Russell, D. and Rose, J. (1986). Social support and adaptation to stress by the elderly. Psychology and Aging, 1, 4754.
De Ronchi, D. et al. (2002). Risk factors for cognitive impairment in HIV-1-infected persons with different risk behaviors. Archives of Neurology, 59, 812818.
Dhalla, S. and Kopec, J. A. (2007). The CAGE questionnaire for alcohol misuse: a review of reliability and validity studies. Clinical and Investigative Medicine, 30, 3341.
Eggers, C. et al. (2017). HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment. Journal of Neurology, 264, 17151727. doi: 10.1007/s00415-017-8503-2.
Fazeli, P. L., Casaletto, K. B., Paolillo, E., Moore, R. C., Moore, D. J. and HNRPO Group (2017). Screening for neurocognitive impairment in HIV-poitive adults aged 50 and over: Montreal Cognitive Assessment relates to self-reported and clinician rated everyday functioning. Journal of Clinical and Experimental Neuropsychology, 39, 842853. doi: 10.1080/13803395.2016.1273319.
Fernandes Filho, S. M. and de Melo, H. R. (2012). Frequency and risk factors for HIV-associated neurocognitive disorder and depression in older individuals with HIV in northeastern Brazil. International Psychogeriatrics, 24, 16481655. doi: 10.1017/S1041610212000944.
Flatt, J. D., Johnson, J. K., Karpiak, S. E., Seidel, L., Larson, B. and Brennan-Ing, M. (2018). Correlates of subjective cognitive decline in lesbian, gay, bisexual, and transgender older adults. Journal of Alzheimer’s Disease, 64, 91102. doi: 10.3233/JAD-171061.
Foley, J. M. et al. (2011). Operationalization of the updated diagnostic algorithm for classifying HIV-related cognitive impairment and dementia. International Psychogeriatrics, 23, 835843. doi: 10.1017/S1041610210002085.
Green, A. F., Rebok, G. and Lyketsos, C. G. (2008). Influence of social network characteristics on cognition and functional status with aging. International Journal of Geriatric Psychiatry, 23, 972978. doi: 10.1002/gps.2023.
Greene, M. et al. (2015). Geriatric syndromes in older HIV-infected adults. Journal of Acquired Immune Deficiency Syndromes, 69, 161167. doi: 10.1097/QAI.0000000000000556.
Greene, M. et al. (2018). Loneliness in older adults living with HIV. AIDS and Behavior, 22, 14751484.
Guralnik, J. M. et al. (2000). Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. The Journal of Gerontology Series A Biological Sciences and Medical Sciences, 55, M221M231.
Hammond, E. and Treisman, G. J. (2007). HIV and psychiatric illness. http://psychiatrictimes.com/articles/hiv-and-psychiatric-illness#sthash.qLdeoOUk.dpuf; last accessed 12 January 2007.
Han, S. D. et al. (2017). Loneliness in older black adults with HIV is associated with poorer cognition. Gerontology, 63, 253262: doi: 10.1159/000455253.
Hays, R. D. and DiMatteo, M. R. (1987). A short-form measure of loneliness. Journal of Personality Assessment, 51, 6981.
Heaton, R. K. et al. (2010). HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER study. Neurology, 75, 20872096.
Heaton, R. K. et al. (2011). HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. Journal of Neurovirology, l17, 316. doi: 10.1007/s13365-010-0006-1.
Hessol, N. A. et al. (2017). Food insecurity and aging outcomes in older adults living with HIV. AIDS and Behavior, 21, 35063514.
Hong, S. and Banks, W. A. (2015). Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications. Brain, Behavior, and Immunity, 45, 112. doi: 10.1016/j.bbi.2014.10.008.
Hughes, T. F., Flatt, J. D., Fu, B., Chang, C. C. and Ganguli, M. (2013). Engagement in social activities and progression from mild to severe cognitive impairment: the MYHAT Study. International Psychogeriatrics, 25, 587595. doi: 10.1017/S1041610212002086.
Jackson, J. D. et al. (2017). Subjective cognitive concerns are associated with objective memory performance in Caucasian but not African-American persons. Age and Ageing, 46, 988993. doi: 10.101093/ageing/afx077.
Janssen, M. A. M., Bosch, M., Koopmans, P. P. and Kessels, R. P. C. (2015). Validity of the Montreal Cognitive Assessment and the HIV Dementia Scale in the assessment of cognitive impairment in HIV-1 infected patients. Journal of Neuorvirology, 21, 383390. doi: 10.1007/s13365-015-0324-4.
John, M. et al. (2016). Geriatric assessments and association with VACS index among HIV-infected older adults in San Francisco. Journal of Acquired Immune Deficiency Syndromes, 72, 534541.
Joska, J. A. et al. (2016). A comparison of five brief screening tools for HIV-associated neurocognitive disorders in the USA and South Africa. AIDS Behavior, 20, 16211631; doi: 10.1007/s10461-016-1316-y.
Justice, A. C. et al. (2010). Towards a combined prognostic index for survival in HIV infection: the role of 'non-HIV’ biomarkers. HIV Medicine, 11, 143151. doi: 10.1111/j.1468-1293.2009.00757.x.
Kallianpur, K. J. et al. (2016). Frailty characteristics in chronic HIV patients are markers of white matter atrophy independently of aging and depressive symptoms: a pilot study. Open Medical Journal, 3, 138152. doi: 10.2174/1874220301603010138.
Katz, S., Ford, A. B., Moskowitz, R. W., Jackson, B. A. and Jaffe, M. W. (1963). Studies of illness in the aged. The Index of ADL: a standardized measure of biological and psychosocial function. Journal of the American Medical Association, 185, 914919.
Kopinsky, K. L., Bao, J. and Lin, Y. W. (2007). Neurobiology of HIV, psychiatric and substance abuse comorbidity research: workshop report. Brain, Behavior, and Immunity, 21, 428441.
Kroenke, K., Spitzer, R. L. and Williams, J. B. (2001). The PHQ-9: validity of a brief depression severity measure. Journal of General Internal Medicine, 16, 606613.
Larner, A. J. (2015). Optimising the cutoffs of cognitive screening instruments in pragmatic diagnostic accuracy studies: maximising accuracy or the Youden index? Dementia and Geriatric Cognitive Disorders, 39, 167175.
Lawton, M. P. and Brody, E. M. (1969). Assessment of older people: self-maintaining and instrumental activities of daily living. The Gerontologist, 9, 179186.
Lee, R. S., Kochman, A. and Sikkema, K. J. (2002). Internalized stigma among people living with HIV-AIDS. AIDS and Behavior, 6, 309319. doi: 10.1023/A:1021144511957
Lees, R., Corbet, S., Johnston, C., Moffitt, E., Shaw, G. and Quinn, T. J. (2013). Test accuracy of short screening tests for diagnosis of delirium or cognitive impairment in an acute stroke unit setting. Stroke, 44, 30783083.
Letendre, S. et al. (2009). Penetration and effectiveness of antiretroviral therapy in the Central Nervous System. Antiinflammatory & Antiallergy Agents in Medicinal Chemistry, 8, 169183.
Lubben, J. E. (1988). Assessing social networks among elderly populations. Family and Community Health, 11, 4252.
Luis, C. A., Keegan, A. P. and Mullan, M. (2009). Cross validation of the Montreal Cognitive Assessment in community dwelling older adults residing in the Southeastern US. International Journal of Geriatric Psychiatry, 24, 197201. doi: 10.1002/gps.2101.
MacArthur, J. C. (2004). HIV dementia: an evolving disease. Journal of Neuroimmunology, 157, 310.
McCutchan, J. A. et al. (2012). Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder. Neurology, 78, 485492.
Milanini, B., Wendelken, L. A., Esmaeili-Firidouni, P., Chartier, M., Crouch, P. C. and Valcour, V. (2014). The Montreal Cognitive Assessment to screen for cognitive impairment in HIV patients older than 60 years. Journal of Acquired Immune Deficiency Syndromes, 67, 6770.
Mukherjee, T. et al. (2018). Utility of using the Montreal Cognitive Assessment (MoCA) as a screening tool for HIV-associated neurocognitive disorders (HAND) in multi-ethnic Malaysia. AIDS Behavior, 22, 32263233. doi: 10.1007/s!0461-018-2073-x.
Nasreddine, Z. (2010). Montreal Cognitive Assessment (MoCA) Administration and Scoring Instructions. Montreal Cognitive Assessment website. http://www.mocatest.org/wp-content/uploads/2015/tests-instructions/MoCA-Instructions-English_2010.pdf. Updated August 18, 2010, last accessed 30 March 2016.
Nath, A., Schiess, N., Venkatesan, A., Rumbaugh, J., Sacktor, N. and MacArthur, J. (2008). Evolution of HIV dementia with HIV infection. International Review of Psychiatry, 20, 2531.
National Comorbidity Survey Replication (NCS-R) . (2005). http://www.hcp.med.harvard.edu/ncs/; last accessed 1 May 2018.
Njamnshi, A. K. et al. (2009). Risk factors for HIV-associated neurocognitive disorders (HAND) in sub-Saharan Africa: the case of Yaounde-Cameroon. Journal of Neurological Sciences, 285, 149153. doi: 10.1016/j.jns.2009.06.043.
Noble, J. M., Schupf, N., Manly, J. J., Andrews, H., Tang, M. X. and Mayeux, R. (2017). Secular trends in the incidence of dementia in a multi-ethnic community. Journal of Alzheimer’s Disease, 60, 10651075. doi:10.3233/JAD-170300.
Olivier, I. S., Cacabelos, R. and Naidoo, V. (2018). Risk factors and pathogenesis of HIV-associated neurocognitive disorder: the role of host genetics. International Journal of Molecular Sciences, 19, 3594. doi: 10.3390/ijms19113594.
Owora, A. H. (2018). Major depression disorder trajectories and HIV disease progression: results from a 6-year outpatient clinic cohort. Medicine, 97, e0252. doi: 10.1097/MD.0000000000010252.
Paul, R. H., Brickman, A. M. and Navia, B. et al. (2005). Apathy is associated with volume of the nucleus accumbens in patients infected with HIV. Journal of Neuropsychiatry and Clinical Neurosciences, 17, 167171.
Rackstraw, S. et al. (2018). Factors associated with HIV associated neurocognitive disorder in an unselected cohort in East and South London – The HAND Study. In Conference Reports for NATAP, Glasgow HIV, 28-31 October 2018, Glasgow, UK.
Rosso, A. L. et al. (2018). Neighborhood socioeconomic status and cognitive function in late life. American Journal of Epidemiology, 183, 10881097. doi: 10.1093/aje/kwv337.
Sacktor, N. et al. (2002). HIV associated cognitive impairment before and after the advent of combination therapy. Journal of Neurovirology, 8, 136142.
San Francisco Department of Public Health Population Health Division (2018). HIV epidemiology annual report 2017. https://www.sfdph.org/dph/files/reports/RptsHIVAIDS/AnnualReport2017-Green-20180904-Web.pdf; last accessed 2 March 2019.
SAS Institute Inc., ed. (2014). SAS/STAT user’s guide, version 9.4. Cary, NC: SAS Institute Inc.
Sattler, F. R. et al. (2015). Abdominal obesity contributes to neurocognitive impairment in HIV-infected patients with increased inflammation and immune activation. Journal of Acquired Immune Deficiency Syndromes, 68, 277284.
Sims, R. C., Levy, S. A., Mwendwa, D. T., Callender, C. O. and Campbell, A. L. (2011). The influence of functional social support on executive functioning in middle-aged African Americans. Aging, Neuropsychology, and Cognition, 18, 414431. doi:10.1080/13825585.2011.567325
Spiegelman, D. and Hertzmark, E. (2005). Easy SAS calculations for risk or prevalence ratios and differences. American Journal of Epidemiology, 162, 199200.
Spitzer, R. L., Kroenke, K., Williams, J. B. and Lowe, B. (2006). A brief measure for assessing generalized anxiety disorder: the GAD-7. Archives of Internal Medicine, 166, 10921097.
Tedaldi, E. M., Minniti, N. L. and Fischer, T. (2015). HIV-associated neurocognitive disorders: the relationship of HIV infection with physical and social comorbidities. BioMed Research International, 2015, Article ID 641913. doi: 10.1155/2015/641913.
Tymchuk, S., Gomez, D., Koenig, N., Gill, M. J., Fujiwara, E. and Power, C. (2018). Associations between depressive symptomatology and neurocognitive impairment in HIV/AIDS. The Canadian Journal of Psychiatry, 63, 329336. doi: 10.1177/0707743717737029.
Valcour, V. G. (2013). HIV, aging, and cognition: emerging issues. Topics in Antiviral Medicine, 21, 119123.
Valcour, V. et al. (2004). Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 Cohort. Neurology, 63, 822827.
Valcour, V. et al. (2012). Over half of HIV-Infected 60 and older have cognitive deficit in San Francisco Study. In 19th Conference on Retroviruses and Opportunistic Infections, Seattle, WA, March 5-8, 2012. www.natap.org/2012/CROI/croi_78.htm (conference abstract).
Vance, D. E. (2013). The cognitive consequences of stigma, social withdrawal, and depression in adults aging with HIV. Journal of Psychosocial Nursing and Mental Health Services, 51, 1820. doi: 10.3928/02793695-20130315-01.
Wang, Z. et al. (2013). High prevalence of HIV-associated neurocognitive disorder in HIV-infected patients with a baseline CD4 count ≤ 350 cells/μL in Shanghai, China. BioScience Trends, 7, 284289.
Watkins, C. C. and Treisman, G. J. (2012). Neuropsychiatric complications of aging with HIV. Journal of Neurovirology, 18, 277290. doi: 10.1007/s13365-012-0108-z.
Watkins, C. C. and Treisman, G. J. (2015). Cognitive impairment in patients with AIDS- prevalence and severity. HIV/AIDS – Research and Palliative Care, 7, 3547.
Weber, E. et al. (2013). Substance use is a risk factor for neurocognitive deficits and neuropsychiatric distress in acute and early HIV infection. Journal of Neurovirology, 19, 6575. doi: 10.1007/s13365-012-0141-y.
Wendelken, L. A. and Valcour, V. (2012). Impact of HIV and aging on neuropsychological function. Journal of Neurovirology, 18, 256263. doi: 10.1007/s13365-012-0094-1.

Keywords

Functional deficits and other psychiatric associations with abnormal scores on the Montreal Cognitive Assessment (MoCA) in older HIV-infected patients

  • James A. Bourgeois (a1), Malcolm John (a2), Roland Zepf (a2), Meredith Greene (a3), Steven Frankel (a4) and Nancy A. Hessol (a5)...

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed